Regarding chromatin remodeling enzymes, ccRCC commonly harbor BAP1 and PBRM1 inactivating mutations (mutated in approximately 15% and 50% of ccRCC cases, respectively) [98]. The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.